0
Psychiatrists, Mental Illness, and Violence
Robert Freedman, M.D.; Randal Ross, M.D.; Robert Michels, M.D.; Paul Appelbaum, M.D.; Larry Siever, M.D.; Renee Binder, M.D.; William Carpenter, M.D.; Susan Hatters Friedman, M.D.; Phillip Resnick, M.D.; Jerrold Rosenbaum, M.D.
Delayed-Onset Posttraumatic Stress Disorder: A Systematic Review of the Evidence
Bernice Andrews, Ph.D.; Chris R. Brewin, Ph.D.; Rosanna Philpott, B.Sc.; Lorna Stewart, M.Sc.
Intensive Psychosocial Intervention Enhances Functioning in Patients With Bipolar Depression: Results From a 9-Month Randomized Controlled Trial
David J. Miklowitz, Ph.D.; Michael W. Otto, Ph.D.; Ellen Frank, Ph.D.; Noreen A. Reilly-Harrington, Ph.D.; Jane N. Kogan, Ph.D.; Gary S. Sachs, M.D.; Michael E. Thase, M.D.; Joseph R. Calabrese, M.D.; Lauren B. Marangell, M.D.; Michael J. Ostacher, M.D.; Jayendra Patel, M.D.; Marshall R. Thomas, M.D.; Mako Araga, M.S.; Jodi M. Gonzalez, Ph.D.; Stephen R. Wisniewski, Ph.D.
CME   Adjunctive Antidepressant Use and Symptomatic Recovery Among Bipolar Depressed Patients With Concomitant Manic Symptoms: Findings From the STEP-BD
Joseph F. Goldberg, M.D.; Roy H. Perlis, M.D.; S. Nassir Ghaemi, M.D., M.P.H.; Joseph R. Calabrese, M.D.; Charles L. Bowden, M.D.; Stephen Wisniewski, Ph.D.; David J. Miklowitz, Ph.D.; Gary S. Sachs, M.D.; Michael E. Thase, M.D.
Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents
Robert D. Gibbons, Ph.D.; C. Hendricks Brown, Ph.D.; Kwan Hur, Ph.D.; Sue M. Marcus, Ph.D.; Dulal K. Bhaumik, Ph.D.; Joëlle A. Erkens, Pharm.D., Ph.D.; Ron M.C. Herings, Pharm.D., Ph.D.; J. John Mann, M.D.
Familial Pathways to Early-Onset Suicidal Behavior: Familial and Individual Antecedents of Suicidal Behavior
Nadine M. Melhem, Ph.D., M.P.H.; David A. Brent, M.D., M.Sc.; Melissa Ziegler, Ph.D.; Satish Iyengar, Ph.D.; David Kolko, Ph.D.; Maria Oquendo, M.D.; Boris Birmaher, M.D.; Ainsley Burke, Ph.D.; Jamie Zelazny, B.S.N.; Barbara Stanley, Ph.D.; J. John Mann, M.D.
CME   Nonresponse to Treatment for Depression Following Myocardial Infarction: Association With Subsequent Cardiac Events
Peter de Jonge, Ph.D.; Adriaan Honig, M.D., Ph.D.; Joost P. van Melle, M.D., Ph.D.; Aart H. Schene, M.D., Ph.D.; Astrid M.G. Kuyper, M.D.; Dorien Tulner, M.D.; Annique Schins, Ph.D.; Johan Ormel, Ph.D.; The MIND-IT Investigators
Differences in PTSD Prevalence and Associated Risk Factors Among World Trade Center Disaster Rescue and Recovery Workers
Megan A. Perrin, M.P.H.; Laura DiGrande, Dr.P.H., M.P.H.; Katherine Wheeler, M.P.H.; Lorna Thorpe, Ph.D.; Mark Farfel, Sc.D.; Robert Brackbill, Ph.D., M.P.H.
Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial
Joo-Cheol Shim, M.D., Ph.D.; Jae-Goo K. Shin, M.D., Ph.D.; Deanna L. Kelly, Pharm.D.; Do-Un Jung, M.D.; Young-Soo Seo, M.D., Ph.D.; Kwang-Hyeon Liu, Ph.D.; Ji-Hong Shon, M.D., Ph.D.; Robert R. Conley, M.D.
Differential Effects of Aripiprazole on D2, 5-HT2, and 5-HT1A Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study
David Mamo, M.D., M.Sc.; Ariel Graff, M.D., Ph.D.; Romina Mizrahi, M.D., Ph.D.; C. M. Shammi, M.D.; Françoise Romeyer, Ph.D.; Shitij Kapur, M.D., Ph.D.
Regional Cortical Thinning in Subjects With Violent Antisocial Personality Disorder or Schizophrenia
Veena M. Narayan, B.S.; Katherine L. Narr, Ph.D.; Veena Kumari, Ph.D.; Roger P. Woods, M.D.; Paul M. Thompson, Ph.D.; Arthur W. Toga, Ph.D.; Tonmoy Sharma, M.D.
Morphology of the Cerebral Cortex in Preclinical Huntington’s Disease
Peg Nopoulos, M.D.; Vincent A. Magnotta, Ph.D.; Ania Mikos, M.S.; Henry Paulson, M.D., Ph.D.; Nancy C. Andreasen, M.D., Ph.D.; Jane S. Paulsen, Ph.D.